← All trials
NCT05179889
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2021
- Primary completion
- Mar 15, 2025
- Completion date
- Mar 15, 2028
- First posted
- Jan 6, 2022
- Last posted
- Jan 6, 2022
- Enrollment
- 308
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chungnam National UniversityLead sponsor
- Chungnam National UniversityOverall official - principal investigator
- Chungnam National UniversityReponsible party - principal investigator
- Boryung Pharmaceutical CompanyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.